MÔ TẢ ĐẶC ĐIỂM LÂM SÀNG BỆNH VÕNG MẠC ĐÁI THÁO ĐƯỜNG TẠI BỆNH VIỆN E TRUNG ƯƠNG

Abstract

Purpose: To describe clinical features of diabetic retinopathy (DR) in E Hospital in 2022-2023. Materials and methods: The study was conducted on a data file of 148 patients (296 eyes) who were diagnosed with diabetes type 1 and 2 in E Hospital from July 2022 to July 2023. Results: In the data file of 148 patients (296 eyes), the proportion of patients with signs of DR was accounted for 47,3%, in which, the ratios of mild non-proliferative DR (R1), moderate non-proliferative DR (R2) and severe non-proliferative DR (R3) were at 37,1%, 20,0% and 37,9% respectively; the rate of  PDR (R4) was the lowest, at 5,0%; the ratio of diabetic macular edema (DME) was 7,4%; only one case that could not be identified DME because of vitreous hemorrhage; research in 140 eyes with DR (R1 to R4), there were some lesions appeared in decreasing frequency: microaneurysm reached to the highest 100%, retinal hemorrhage stood at a half, hard exudate (38,6%), cotton wood (20,7%), venous beading (5,0%), new vessel (4,3%), vascular loop (2,1%), IRMA and vitreous hemorrhage (0,7%). Conclusion: The proportion of DR tends to be increasing. The retinal damage of patients with DR is mainly at the R0 stage which means no clinical manifestations, thus screening DR plays an important role to prevent patients from losing their vision acuity permanently. Therefore, controlling diabetes well at general hospital is essential to reduce serious diabetic complications, especially in retina.